BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18337501)

  • 1. Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation.
    Presto J; Thuveson M; Carlsson P; Busse M; Wilén M; Eriksson I; Kusche-Gullberg M; Kjellén L
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4751-6. PubMed ID: 18337501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatically active N-deacetylase/N-sulfotransferase-2 is present in liver but does not contribute to heparan sulfate N-sulfation.
    Ledin J; Ringvall M; Thuveson M; Eriksson I; Wilén M; Kusche-Gullberg M; Forsberg E; Kjellén L
    J Biol Chem; 2006 Nov; 281(47):35727-34. PubMed ID: 16984905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dominant negative splice variant of the heparan sulfate biosynthesis enzyme NDST1 reduces heparan sulfate sulfation.
    Missaghian P; Dierker T; Khosrowabadi E; Axling F; Eriksson I; Ghanem A; Kusche-Gullberg M; Kellokumpu S; Kjellén L
    Glycobiology; 2022 May; 32(6):518-528. PubMed ID: 35137078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation.
    Busse M; Feta A; Presto J; Wilén M; Grønning M; Kjellén L; Kusche-Gullberg M
    J Biol Chem; 2007 Nov; 282(45):32802-10. PubMed ID: 17761672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of heparan sulfate in EXT1-deficient cells.
    Okada M; Nadanaka S; Shoji N; Tamura J; Kitagawa H
    Biochem J; 2010 May; 428(3):463-71. PubMed ID: 20377530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro heparan sulfate polymerization: crucial roles of core protein moieties of primer substrates in addition to the EXT1-EXT2 interaction.
    Kim BT; Kitagawa H; Tanaka J; Tamura J; Sugahara K
    J Biol Chem; 2003 Oct; 278(43):41618-23. PubMed ID: 12907685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of different isoforms of glucosaminyl N-deacetylase/N-sulfotransferase results in distinct heparan sulfate N-sulfation patterns.
    Pikas DS; Eriksson I; Kjellén L
    Biochemistry; 2000 Apr; 39(15):4552-8. PubMed ID: 10758005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDST2 (N-Deacetylase/N-Sulfotransferase-2) Enzyme Regulates Heparan Sulfate Chain Length.
    Deligny A; Dierker T; Dagälv A; Lundequist A; Eriksson I; Nairn AV; Moremen KW; Merry CLR; Kjellén L
    J Biol Chem; 2016 Sep; 291(36):18600-18607. PubMed ID: 27387504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.
    Ushakov VS; Tsidulko AY; de La Bourdonnaye G; Kazanskaya GM; Volkov AM; Kiselev RS; Kobozev VV; Kostromskaya DV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression of EXT1 and EXT2 during mouse brain development.
    Inatani M; Yamaguchi Y
    Brain Res Dev Brain Res; 2003 Mar; 141(1-2):129-36. PubMed ID: 12644256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau
    Stopschinski BE; Holmes BB; Miller GM; Manon VA; Vaquer-Alicea J; Prueitt WL; Hsieh-Wilson LC; Diamond MI
    J Biol Chem; 2018 Jul; 293(27):10826-10840. PubMed ID: 29752409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exostosin-like 2 regulates FGF2 signaling by controlling the endocytosis of FGF2.
    Nadanaka S; Kitagawa H
    Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):791-799. PubMed ID: 29305908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An altered heparan sulfate structure in the articular cartilage protects against osteoarthritis.
    Severmann AC; Jochmann K; Feller K; Bachvarova V; Piombo V; Stange R; Holzer T; Brachvogel B; Esko J; Pap T; Hoffmann D; Vortkamp A
    Osteoarthritis Cartilage; 2020 Jul; 28(7):977-987. PubMed ID: 32315715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic fibroblasts with a gene trap mutation in Ext1 produce short heparan sulfate chains.
    Yamada S; Busse M; Ueno M; Kelly OG; Skarnes WC; Sugahara K; Kusche-Gullberg M
    J Biol Chem; 2004 Jul; 279(31):32134-41. PubMed ID: 15161920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity.
    Cheung PK; McCormick C; Crawford BE; Esko JD; Tufaro F; Duncan G
    Am J Hum Genet; 2001 Jul; 69(1):55-66. PubMed ID: 11391482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.
    McCormick C; Duncan G; Goutsos KT; Tufaro F
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):668-73. PubMed ID: 10639137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate synthesized by mouse embryonic stem cells deficient in NDST1 and NDST2 is 6-O-sulfated but contains no N-sulfate groups.
    Holmborn K; Ledin J; Smeds E; Eriksson I; Kusche-Gullberg M; Kjellén L
    J Biol Chem; 2004 Oct; 279(41):42355-8. PubMed ID: 15319440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowered expression of heparan sulfate/heparin biosynthesis enzyme N-deacetylase/n-sulfotransferase 1 results in increased sulfation of mast cell heparin.
    Dagälv A; Holmborn K; Kjellén L; Abrink M
    J Biol Chem; 2011 Dec; 286(52):44433-40. PubMed ID: 22049073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct effects on heparan sulfate structure by different active site mutations in NDST-1.
    Bengtsson J; Eriksson I; Kjellén L
    Biochemistry; 2003 Feb; 42(7):2110-5. PubMed ID: 12590599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier.
    Khalil R; Boels MGS; ; van den Berg BM; Bruijn JA; Rabelink TJ; Hogendoorn PCW; Baelde HJ
    Mol Genet Genomics; 2022 Mar; 297(2):397-405. PubMed ID: 35103870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.